Side effects in patients taking Pregabalins targeting Xerostomia [Efectos secundarios en pacientes que consumen Pregabalinas enfocadas en la Xerostomía]
DOI:
https://doi.org/10.62574/p65h1937Keywords:
xerostomia, Sjogren’s syndrome, salivary gland fistulaAbstract
Objective: to identify side effects in patients taking Pregabalins focused on Xerostomia. Method: systematic review. Results and Conclusion: Pregabalin use is associated with xerostomia as a significant side effect, impacting essential oral functions such as chewing, swallowing and phonation, and increasing the risk of caries, oral infections and periodontal alterations. A higher incidence of this adverse effect is observed in polymedicated patients, older adults and those with pre-existing conditions, such as hypertension and autoimmune diseases.
Downloads
References
Millsop JW, Wang EA, Fazel N. Etiology, evaluation, and management of xerostomia. Clin Dermatol. 2017;35(5):468-476. doi:10.1016/j.clindermatol.2017.06.010
Tanasiewicz M, Hildebrandt T, Obersztyn I. Xerostomia of Various Etiologies: A Review of the Literature. Adv Clin Exp Med. 2016;25(1):199-206. doi:10.17219/acem/29375
Dreyer NS, Lynggaard CD, Jakobsen KK, Pedersen AML, von Buchwald C, Grønhøj C. Ugeskr Laeger. 2021;183(27):V11200814.
Barbe AG. Medication-Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management. Drugs Aging. 2018;35(10):877-885. doi:10.1007/s40266-018-0588-5
Gil-Montoya JA, Silvestre FJ, Barrios R, Silvestre-Rangil J. Treatment of xerostomia and hyposalivation in the elderly: A systematic review. Med Oral Patol Oral Cir Bucal. 2016;21(3):e355-e366. Published 2016 May 1. doi:10.4317/medoral.20969
Thakkar JP, Lane CJ. Hyposalivation and Xerostomia and Burning Mouth Syndrome: Medical Management. Oral Maxillofac Surg Clin North Am. 2022;34(1):135-146. doi:10.1016/j.coms.2021.08.002
Paz C, Glassey A, Frick A, et al. Cancer therapy-related salivary dysfunction. J Clin Invest. 2024;134(17):e182661. Published 2024 Sep 3. doi:10.1172/JCI182661
Grover SS, Rhodus NL. Xerostomia and Depression. Northwest Dent. 2016;95(3):29-35.
Agbo-Godeau S, Guedj A, Marès S, Goudot P. Sécheresse buccale (xérostomie) [Xerostomia]. Presse Med. 2017;46(3):296-302. doi:10.1016/j.lpm.2017.02.004
Kim YJ. Xerostomia and Its Cellular Targets. Int J Mol Sci. 2023;24(6):5358. Published 2023 Mar 10. doi:10.3390/ijms24065358
Ozasa K, Nishihara C, Watanabe K, et al. Somatosensory profile of a patient with mixed connective tissue disease and Sjögren syndrome. J Am Dent Assoc. 2020;151(2):145-151. doi:10.1016/j.adaj.2019.09.001
Ramírez L, Sánchez I, Muñoz M, et al. Risk factors associated with xerostomia and reduced salivary flow in hypertensive patients. Oral Dis. 2023;29(3):1299-1311. doi:10.1111/odi.14090
Kim YJ. Xerostomia: Advances and Challenges in Drug Development. Curr Drug Targets. 2024;25(5):301-305. doi:10.2174/0113894501293941240228050343
Gómez-Moreno G, Valerón-Rodríguez F. Pseudomembranous oral candidiasis resolved with a mouthwash containing 0.05% chlorhexidine + 0.05% cetylpyridinium chloride. Eur Rev Med Pharmacol Sci. 2021;25(18):5725-5728. doi:10.26355/eurrev_202109_26790
Malallah OS, Garcia CMA, Proctor GB, Forbes B, Royall PG. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth). Int J Pharm. 2018;541(1-2):157-166. doi:10.1016/j.ijpharm.2018.02.004
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Copyright (c) 2024 By the authors. This article is open access and distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) licence (https://creativecommons.org/licenses/by-nc-sa/4.0/).
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
